Vimarsana
Biggest News Aggregation in the World

Page 5 - Biochemical Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biochemical Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biochemical Sciences Today - Breaking & Trending Today

Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors - Vimarsana News

Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

Published: May 26, 2022

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced a series of actions as part of its ongoing commitment to strong corporate governance and regular...

Source: prnewswire.com
Related Topics:
Harvard UniversityUnited StatesUnited KingdomAlex DennerKatie JoyceEmily Peterson AlvaDavida DaglioNancyj WysenskiCatot LaurencinChristopher WrightBrianp MckeonWendyl DixonVrije UniversiteitSandy CoombsChristopheri WrightIronwood Pharmaceuticals IncGlobal Medicines DevelopmentCorporate Governance CommitteeCorporate Governance Committee Of The BoardHarvard Medical SchoolAavantibio IncVertex Pharmaceuticals IncorporatedAxcella Health IncProfessor Of Neurology At Harvard Medical SchoolCyclerion Therapeutics Inc
Alkermes plc: Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors - Vimarsana News

Alkermes plc: Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

Published: May 26, 2022

- Appoints Nancy J. Wysenski as New Lead Independent Director - - David W. Anstice AO and Wendy L. Dixon, Ph.D. to Retire From Board - - Files Preliminary Proxy Statement and Highlights

Source: finanznachrichten.de
Related Topics:
Harvard UniversityUnited StatesUnited KingdomAlex DennerKatie JoyceEmily Peterson AlvaDavida DaglioNancyj WysenskiCatot LaurencinBrianp MckeonChristopher WrightWendyl DixonVrije UniversiteitSandy CoombsChristopheri WrightIronwood Pharmaceuticals IncGlobal Medicines DevelopmentCorporate Governance Committee Of The BoardVertex Pharmaceuticals IncorporatedAxcella Health IncProfessor Of Neurology At Harvard Medical SchoolCyclerion Therapeutics IncCorporate Governance CommitteeHarvard Medical SchoolAavantibio Inc
Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors - Vimarsana News

Alkermes Announces Continued Board Refreshment, Including the Appointment of Christopher I. Wright, M.D., Ph.D. to its Board of Directors

Published: May 26, 2022

/PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) today announced a series of actions as part of its ongoing commitment to strong corporate governance and regular...

Source: prnewswire.com
Related Topics:
Harvard UniversityUnited StatesUnited KingdomAlex DennerKatie JoyceEmily Peterson AlvaDavida DaglioNancyj WysenskiCatot LaurencinChristopher WrightBrianp MckeonWendyl DixonVrije UniversiteitSandy CoombsChristopheri WrightIronwood Pharmaceuticals IncGlobal Medicines DevelopmentCorporate Governance CommitteeCorporate Governance Committee Of The BoardHarvard Medical SchoolAavantibio IncVertex Pharmaceuticals IncorporatedAxcella Health IncProfessor Of Neurology At Harvard Medical SchoolCyclerion Therapeutics Inc
Longeveron Inc. Provides Corporate Update and Reports First - Vimarsana News

Longeveron Inc. Provides Corporate Update and Reports First

Published: May 13, 2022

Conference call scheduled for 8:30 a.m. ET today...

Source: globenewswire.com
Related Topics:
United StatesNova ScotiaTodd GirolamoElsie YauVagelos College Of PhysiciansCaladrius Biosciences IncJournal Of The Alzheimer AssociationJuntendo University Hospital TokyoRockefeller UniversityBlood InstituteNational CenterMerck Research LaboratoriesDrug AdministrationLongeveron IncColumbia UniversityExchange CommissionCorporate DevelopmentWeill Medical College Of Cornell UniversityNational Institute Of Health HeartHarvard CollegeColumbia Business SchoolLongeveron Or CompanyBiochemical SciencesUniversity Of Pennsylvania Law SchoolQuarter Business Updates
Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results - Vimarsana News

Longeveron Inc. Provides Corporate Update and Reports First Quarter 2022 Financial Results

Published: May 13, 2022

13.05.2022 - Conference call scheduled for 8:30 a.m. ET todayMIAMI, May 13, 2022 (GLOBE NEWSWIRE) - Longeveron Inc. (NASDAQ: LGVN) ('Longeveron' or 'Company'), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and ...

Source: wallstreet-online.de
Related Topics:
United StatesNova ScotiaTodd GirolamoElsie YauVagelos College Of PhysiciansCaladrius Biosciences IncJournal Of The Alzheimer AssociationJuntendo University Hospital TokyoRockefeller UniversityBlood InstituteNational CenterMerck Research LaboratoriesForgiveness Of Paycheck Protection ProgramDrug AdministrationLongeveron IncColumbia UniversityExchange CommissionCorporate DevelopmentWeill Medical College Of Cornell UniversityNational Institute Of Health HeartHarvard CollegeColumbia Business SchoolBiochemical SciencesUniversity Of Pennsylvania Law SchoolHypoplastic Left Heart Syndrome